Serum lipid profiles and aggressive prostate cancer  

作　　者：Yanjing Li Chaozhao Liang Jiaoti Huang 

机构地区：[1]Department of Pathology and Urology, Jonsson Comprehensive Cancer Center and Broad Center for Regenerative Medicine and Stem Cell Biology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA [2]Department of Urology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.

出　　处：《Asian Journal of Andrology》2015年第2期336-336,共1页亚洲男性学杂志（英文版）

摘　　要：The introduction of widespread prostate specific antigen （PSA） screening in western countries led to a sharp increase in prostate biopsies and the subsequent diagnosis of prostate cancer. This phenomenon appears to be repeating itself in countries such as China where economic development in recent decades has resulted in increased access to healthcare and more frequent screening tests. It is now recognized that the majority of prostate cancers diagnosed in PSA-screened men is of the indolent nature that does not impact patients＇ quality of life or life expectancy. Unfortunately, due to our inability to image prostate cancer accurately,The introduction of widespread prostate specific antigen （PSA） screening in western countries led to a sharp increase in prostate biopsies and the subsequent diagnosis of prostate cancer. This phenomenon appears to be repeating itself in countries such as China where economic development in recent decades has resulted in increased access to healthcare and more frequent screening tests. It is now recognized that the majority of prostate cancers diagnosed in PSA-screened men is of the indolent nature that does not impact patients＇ quality of life or life expectancy. Unfortunately, due to our inability to image prostate cancer accurately,

分 类 号：Q78[生物学—分子生物学] TS201.22[轻工技术与工程—食品科学]